Ai-lin Zhao
Beijing, 100730, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Correction: Phase 2 study of oral thalidomide-cyclophosphamide-dexamethasone for recurrent/refractory adult Langerhans cell histiocytosis.
Journal: Leukemia
Published: February 09, 2023
The potential of cell-free DNA to reveal the molecular profiles of Langerhans cell histiocytosis and Erdheim-Chester disease in adults.
Journal: Leukemia
Published: November 23, 2021
Treatment outcomes and prognostic factors of patients with adult Langerhans cell histiocytosis.
Journal: American journal of hematology
Published: October 13, 2021
Diverse kinase alterations and myeloid-associated mutations in adult histiocytosis.
Journal: Leukemia
Published: July 09, 2021
Methotrexate and cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis: A single arm, single center, prospective phase 2 study.
Journal: American journal of hematology
Published: March 04, 2020
Early or deferred treatment of smoldering multiple myeloma: a meta-analysis on randomized controlled studies.
Journal: Cancer management and research
Published: February 16, 2019
The role of high serum CXCL13 level in Waldenström macroglobulinemia.
Journal: Leukemia research
Published: November 12, 2018
Increased activated regulatory T cell subsets and aging Treg-like cells in multiple myeloma and monoclonal gammopathy of undetermined significance: a case control study.
Journal: Cancer cell international
Published: September 25, 2018
Successful Treatment of Erdheim-Chester Disease With Coronary Artery Involvement.
Journal: The Canadian journal of cardiology
Published: August 28, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026